A detailed history of Prospera Financial Services Inc transactions in Merck & Co., Inc. stock. As of the latest transaction made, Prospera Financial Services Inc holds 193,018 shares of MRK stock, worth $19.2 Million. This represents 0.57% of its overall portfolio holdings.

Number of Shares
193,018
Previous 183,631 5.11%
Holding current value
$19.2 Million
Previous $22.7 Million 3.58%
% of portfolio
0.57%
Previous 0.65%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$111.15 - $128.97 $1.04 Million - $1.21 Million
9,387 Added 5.11%
193,018 $21.9 Million
Q2 2024

Aug 13, 2024

BUY
$123.8 - $132.96 $7.76 Million - $8.33 Million
62,673 Added 51.81%
183,631 $22.7 Million
Q1 2024

Aug 13, 2024

SELL
$113.24 - $131.95 $4.74 Million - $5.52 Million
-41,816 Reduced 22.77%
141,815 $18.7 Million
Q4 2023

Feb 14, 2024

BUY
$100.18 - $109.02 $937,584 - $1.02 Million
9,359 Added 8.39%
120,958 $13.2 Million
Q3 2023

Nov 13, 2023

BUY
$102.95 - $114.33 $1.93 Million - $2.14 Million
18,709 Added 20.14%
111,599 $11.5 Million
Q2 2023

Aug 08, 2023

SELL
$108.61 - $118.38 $812,185 - $885,245
-7,478 Reduced 7.45%
92,890 $10.7 Million
Q1 2023

May 12, 2023

BUY
$102.94 - $114.86 $497,097 - $554,658
4,829 Added 5.05%
100,368 $10.7 Million
Q4 2022

Feb 08, 2023

SELL
$87.44 - $112.11 $3.77 Million - $4.83 Million
-43,084 Reduced 31.08%
95,539 $10.6 Million
Q3 2022

Oct 27, 2022

BUY
$84.53 - $94.96 $1.19 Million - $1.34 Million
14,102 Added 11.32%
138,623 $11.9 Million
Q2 2022

Aug 08, 2022

BUY
$83.49 - $94.64 $2.96 Million - $3.36 Million
35,477 Added 39.84%
124,521 $11.4 Million
Q1 2022

May 04, 2022

BUY
$73.51 - $82.4 $1.96 Million - $2.19 Million
26,638 Added 42.68%
89,044 $7.31 Million
Q4 2021

Feb 10, 2022

BUY
$72.28 - $90.54 $258,111 - $323,318
3,571 Added 6.07%
62,406 $4.79 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $2,723 - $2,995
38 Added 0.06%
58,835 $4.42 Million
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $98.8 Million - $109 Million
-1,404,891 Reduced 95.98%
58,797 $4.57 Million
Q2 2021

Aug 12, 2021

BUY
$70.31 - $77.77 $99.4 Million - $110 Million
1,413,313 Added 2805.58%
1,463,688 $3.17 Million
Q1 2021

May 06, 2021

BUY
$68.86 - $81.11 $11,775 - $13,869
171 Added 0.34%
50,375 $3.89 Million
Q4 2020

Feb 12, 2021

BUY
$71.77 - $79.65 $1.23 Million - $1.37 Million
17,168 Added 51.97%
50,204 $4.11 Million
Q3 2020

Nov 04, 2020

SELL
$73.18 - $82.95 $956,169 - $1.08 Million
-13,066 Reduced 28.34%
33,036 $2.74 Million
Q2 2020

Aug 07, 2020

BUY
$70.42 - $80.13 $1.94 Million - $2.2 Million
27,500 Added 147.83%
46,102 $3.57 Million
Q1 2020

May 15, 2020

SELL
$63.36 - $87.82 $1.83 Million - $2.53 Million
-28,821 Reduced 60.77%
18,602 $1.43 Million
Q4 2019

Feb 12, 2020

BUY
$77.58 - $87.54 $2.11 Million - $2.38 Million
27,196 Added 134.45%
47,423 $4.31 Million
Q3 2019

Oct 22, 2019

BUY
$76.08 - $82.93 $96,469 - $105,155
1,268 Added 6.69%
20,227 $1.7 Million
Q2 2019

Aug 14, 2019

SELL
$69.84 - $81.59 $56,151 - $65,598
-804 Reduced 4.5%
17,048 $1.3 Million
Q2 2019

Aug 14, 2019

BUY
$69.84 - $81.59 $133,464 - $155,918
1,911 Added 11.21%
18,959 $1.6 Million
Q1 2019

May 02, 2019

BUY
$69.58 - $79.36 $55,942 - $63,805
804 Added 4.72%
17,852 $1.45 Million
Q4 2018

Feb 13, 2019

BUY
$65.24 - $75.71 $159,446 - $185,035
2,444 Added 16.74%
17,048 $1.3 Million
Q3 2018

Oct 25, 2018

SELL
$57.69 - $67.84 $96,284 - $113,224
-1,669 Reduced 10.26%
14,604 $926,000
Q2 2018

Jul 18, 2018

BUY
$50.83 - $59.72 $62,012 - $72,858
1,220 Added 8.1%
16,273 $992,000
Q1 2018

Apr 12, 2018

BUY
$50.96 - $59.23 $280,127 - $325,587
5,497 Added 57.52%
15,053 $821,000
Q4 2017

Jan 24, 2018

SELL
$51.62 - $61.64 $75,520 - $90,179
-1,463 Reduced 13.28%
9,556 $540,000
Q3 2017

Oct 11, 2017

BUY
$58.67 - $63.13 $646,484 - $695,629
11,019
11,019 $707,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $251B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Prospera Financial Services Inc Portfolio

Follow Prospera Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prospera Financial Services Inc with notifications on news.